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GDP-D-mannose 4,6-dehydratase (GMD) is a key enzyme
involved in the synthesis of 6-deoxyhexoses in prokaryotes and
eukaryotes. Paramecium bursaria chlorella virus-1 (PBCV-1)
encodes a functional GMD, which is unique among character-
ized GMDs because it also has a strong stereospecific NADPH-
dependent reductase activity leading to GDP-D-rhamnose for-
mation (Tonetti, M., Zanardi, D., Gurnon, J., Fruscione, F.,
Armirotti, A., Damonte, G., Sturla, L., De Flora, A., and Van
Etten, J.L. (2003) J. Biol. Chem. 278, 21559–21565). In the pres-
ent study we characterized a recombinant GMD encoded by
another chlorella virus, Acanthocystis turfacea chlorella virus 1
(ATCV-1), demonstrating that it has the expected dehydratase
activity. However, it also displayed significant differences when
compared with PBCV-1 GMD. In particular, ATCV-1 GMD lacks
thereductaseactivitypresent inthePBCV-1enzyme.Usingrecom-
binant PBCV-1 andATCV-1GMDs,wedetermined that the enzy-
matically active proteins contain tightly bound NADPH and that
NADPH is essential for maintaining the oligomerization status as
well as for the stabilizationand functionofbothenzymes.Phyloge-
neticanalysis indicates thatPBCV-1GMDis themostevolutionary
diverged of theGMDs.We conclude that this high degree of diver-
gencewas the result of the selectionpressures that led to the acqui-
sition of new reductase activity to synthesize GDP-D-rhamnose
while maintaining the dehydratase activity in order to continue to
synthesize GDP-L-fucose.
GDP-D-mannose 4,6-dehydratase (GMD,2 EC 4.2.1.47) is the
first enzyme in the biosynthetic pathways that leads to the for-
mation of several deoxyhexoses, such as GDP-L-fucose (1),
GDP-D-rhamnose (2), GDP-6-deoxy-D-talose (3), and GDP-D-
perosamine (4). Genes encoding GMDs have been identified in
most prokaryotes and eukaryotes (5–8). Recently, we charac-
terized the firstGMDencoded by a virus,Parameciumbursaria
chlorella virus 1 (PBCV-1) (9). PBCV-1 is the prototype of a
group (family Phycodnaviridae) of large, icosahedral, plaque-
forming, double-stranded DNA viruses that replicate in certain
unicellular, eukaryotic chlorella-like green algae (10). In nature,
the chlorella host is a hereditary endosymbiont in the ciliatedpro-
tozoan P. bursaria. PBCV-1 has 365 protein-encoding genes,
including genes that encode several proteins that resemble
enzymes involved in the metabolism and processing of sugars;
these proteins include five putative glycosyltransferases believed
tobe involved in theglycosylationof thevirusmajorcapsidprotein
(11). PBCV-1 also encodes the two enzymes involved in GDP-L-
fucose biosynthesis, GMD and GDP-4-keto-6-deoxy-D-mannose
epimerase/reductase (GMER) (Fig. 1) (9).
GMD is a member of the short-chain dehydrogenase/reduc-
tase family of proteins (12) and in general has structural fea-
tures compatible with enzymes belonging to the reductase-epi-
merase-dehydrogenase superfamily (13). GMD sequences are
well conserved among organisms; they all contain three con-
served amino acids, Ser/Thr, Tyr, and Lys, involved in catalysis
and a glycine-rich motif at the N terminus that is involved in
cofactor binding. GMD three-dimensional structures have
been reported from several organisms (14–17). GMD binds its
coenzymeNADP(H) in the N-terminal domain, which consists
of a seven-stranded Rossman fold, whereas the C-terminal
domain is involved in substrate binding. The PBCV-1 GMD
crystal structurewas determined at 3.8Å resolution (17), and its
tertiary structure resembles other GMDs. However, the low
resolution of the PBCV-1 crystals did not provide definitive
information on the structure of the active site nor did it allow
the identification of the redox state of the coenzyme.
The catalytic mechanism proposed for GMD is similar to
that reported for other nucleotide sugars dehydratases, such as
dTDP-D-glucose dehydratase and CDP-D-glucose dehydratase
(18–19). The presence of an oxidized coenzyme (NADP in the
case of GMD) is required for the beginning of the catalytic
cycle. Initially, a hydride is transferred fromC-4 of themannose
moiety to NADP, which is accordingly reduced to NADPH,
with the formation of a 4-keto-intermediate (14). At this stage
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two different mechanisms have been proposed; a proton is
removed from C-5 by a base on the enzyme followed by dehy-
dration of the 4-keto-intermediate between C-5 and C-6 yield-
ing a 4-keto-5,6-ene species. In the secondmechanism a 4-ene-
diol/enolate species is formed in the second step of the reaction.
In both cases a conserved acid residue (Glu-135 in Escherichia
coli sequence) has been proposed to act as a base that removes
a proton fromC-6 (14). The final step in the reaction involves a
hydride transfer from bound NADPH to C-6 of the sugar, lead-
ing to the productGDP-4-keto-6-deoxy-D-mannose and regen-
eration of NADP. GDP-4-keto-6-deoxy-D-mannose is the
substrate for GMER; however, it is not a very stable compound.
Thus, the presence of an oxidized coenzyme is an absolute
requirement for initiating GMD activity. However, structural
data obtained by x-ray crystallography indicated that bothAra-
bidopsis thaliana and Pseudomonas aeruginosa GMD contain
only tightly boundNADPH instead ofNADP (15–16). Prelim-
inary data obtained in our laboratory also indicate thatNADPH
is present in recombinant GMD from virus PBCV-1.3
The PBCV-1 recombinant GMDdiffers from other currently
characterized GMDs because, in addition to the dehydratase
activity, the protein also has a strong stereospecific NADPH-
dependent reductase activity that produces GDP-D-rhamnose
(9). The low resolution of the active site in the PBCV-1 GMD
crystals (17) did not provide any information thatwould explain
the high reductase activity of the enzyme. However, a reductase
activity implies an exchange between the oxidized form of the
bound coenzyme and the exogenous NADPH added to the
reaction mixture.
Recently, the genome of another virus (Acanthocystis turfa-
cea chlorella virus (ATCV-1)) that infects Chlorella SAG 3.83
was sequenced (20). ATCV-1 also contains genes encoding
putative GMDandGMER enzymes. However, the GMDamino
acid sequences fromATCV-1 and PBCV-1 only have 53% iden-
tity, suggesting the two enzymes have undergone significant
divergence and that they might have different properties.
To address the presence and possible role of NADPH in the
structural and catalytic properties of GMD,we expressedGMD
from both PBCV-1 and ATCV-1 viruses and analyzed their
kinetic and structural properties, their coenzyme content, and
their coenzyme binding affinities. The results described here
indicate that the ATCV-1 protein has dehydratase activity on
GDP-D-mannose, but that it lacks the reductase activity present
in PBCV-1 GMD. Moreover, we demonstrate that the catalyti-
cally active forms of both proteins contain NADPH, which is
essential for stabilizing the enzyme structure. We propose that
the presence of NADPH in these two dehydratases, even if not
involved in the catalytic process, is not incidental but that it
serves an important role in enzyme function.
EXPERIMENTAL PROCEDURES
Expression and Purification of Recombinant GMDProteins—
GMD proteins were expressed in E. coli as glutathione
S-transferase fusion proteins as previously described (9)
using pGEX-6P1 vector (GE Healthcare). The ATCV-1 GMD
sequence corresponds to open reading frame Z804L in
ATCV-1 genome (GenBankTM accession number EF101928).
Purification to homogeneity was achieved by chromatography
on a GSH-Sepharose 4B column followed by in situ proteolytic
cleavage of the tag by Prescission Protease (GE Healthcare).
The proteins were concentrated to about 4–6 mg/ml using a
Centricon YM-10 system (Amicon-Millipore) and stored at
4 °C in 50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, pH 7.0
(TBSE) containing 1mM dithiothreitol (DTT). ApoGMDswere
prepared after preincubation of the proteins with GDP-4-keto-
6-deoxy-D-mannose followed by dialysis against 1000 volumes
of TBSE/DTT. This treatment resulted in complete removal of
bound coenzymes (see below).
Protein concentrations were determined by UV280 absorb-
ance of the purified proteins in 6 M guanidine hydrochloride,
0.02 M phosphate buffer, pH 6.5, using a calculated extinction
coefficient of 47,330 M1 cm1 for PBCV-1 GMD and 51,340
M1 cm1 for ATCV-1 GMD (21). Because the holoenzyme
contains bound NADP(H), which can interfere with the UV280
assay, protein concentrations were also determined by the
Bradford procedure (Bio-Rad) using apoGMD as a standard.
GMDconcentrationwas expressed asmolarity of themonomer
form of the protein. Protein purity, monitored by SDS-PAGE,
exceeded 95% in all preparations.
Determination of GMD-bound NADP/NADPH—The
amounts of protein-bound NADP and NADPH were deter-
mined by reverse phase HPLC on either untreated purified
GMD or after preincubation of the proteins (100 M) with a
molar excess of GDP-4-keto-6-deoxy-D-mannose (150 M).
This latter treatment converts all bound NADPH to the oxi-
dized form (see below). Aliquots of both the untreated and
treated proteins were dialyzed to verify coenzyme release from
GMD. The concentrated protein (100 M) was then dialyzed
against 1000 volumes of TBSE/DTT for 24 h at 4 °C.
To discriminate between NADP and NADPH, the proteins
were subjected to treatments that selectively destroy the oxi-
dized and reduced forms of NADP before analysis (22). For3 M. Tonetti, E. Di Zanni, L. Sturla, and F. Fruscione, unpublished results.
FIGURE 1. Biosynthetic pathway of GDP-L-fucose from GDP-D-mannose.
GDP-D-mannose is converted to GDP-4-keto-6-deoxy-D-mannose by GMD.
One proposed mechanism of dehydration is shown in brackets. A hydride is
transferred from C-4 of GDP-D-mannose (A) to protein bound NADP
(E-NADP), which becomes reduced, to form a 4-keto-intermediate (B). A
water molecule is lost with the formation of 4-keto-5,6-ene intermediate (C).
Protein-bound NADPH (E-NADPH) reduces C-6 with consequent formation of
GMD final product (D) and regeneration of E-NADP. GDP-4-keto-6-deoxy-D-
mannose then undergoes an epimerization and a NADPH-dependent reduc-
tion, both catalyzed by GMER, to form GDP-L-fucose. Alternatively, GDP-4-
keto-6-deoxy-D-mannose can undergo a NADPH-dependent reduction
catalyzed by PBCV-1 GMD to form GDP-D-rhamnose.
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NADP determination, 100 l of protein solution (50 M,
expressed as the monomer) or NADP/NADPH standards in
TBSE buffer were first treated with 10 l of 3.7 M HClO4. Sam-
ples were then neutralized with 3 M K2CO3, and the precipitate
was removed by centrifugation; 100 l of supernatant were
diluted 1:1 with TBSE and subjected to HPLC analysis. For
NADPHdetermination, 5l of 4 NNaOHwere added to 100l
of proteins or standards in TBSE; samples were heated at 70 °C
for 10min and immediately chilled in ice. These solutions were
then neutralized by adding 4 NHCl and centrifuged. The super-
natants were diluted as described above.
HPLC analysis was performed with an HP 1090 apparatus
(Agilent) equipped with a Diode Array Detector and fitted with
a reverse phase C18 column (25  300 cm, 5-m particle size,
Waters) as described (23). The eluate wasmonitored at 260 and
340 nm. Concentrations of NADP(H) (obtained from Sigma)
were determined using an extinction coefficient of 17,800 M1
cm1 at 260 nm for NADP and an extinction coefficient of
6,220 M1 cm1 at 340 nm for NADPH. HPLC analysis of
standard NADPH revealed no contamination by the oxidized
form. Coenzyme concentrations in the samples were obtained
by linear regression using the Prism 5.0 program (Graphpad).
FluorescenceAnalyses—All fluorescencemeasurementswere
performed at 22 °C using a PerkinElmer Life Sciences LS50B
spectrofluorimeter in a 0.5  0.5-cm quartz cuvette. Emission
spectra were recorded with freshly diluted protein to a 1 M
concentration in PBS, pH7.3, froma 100Meither untreated or
GDP-4-keto-6-deoxy-D-mannose-treatedGMDsolution. After
dilution, protein solutions were allowed to equilibrate until
reaching stable fluorescence intensities. Enzyme-bound
NADPH was determined using the excitation wavelength at
350 nm (5-nm slit width) and recording fluorescence emission
from 370 to 600 nm (10-nm slit width). Intrinsic tryptophan
fluorescence and fluorescence energy transfer were measured
with an excitation of 295 nm (5-nmslit width)whilemonitoring
emission from 310 to 500 nm (10-nm slit width). Sample spec-
tra were corrected for background and Raman scattering by
subtracting buffer spectra.
Fluorescence titration experiments were used to determine
the binding affinities of the cofactors to the apoenzymes. Pro-
tein concentrations in PBS were 500 nM for both NADP and
NADPH titrations. Solutions were prepared immediately
before use, and the concentrations were determined as
described above. NADP binding to protein was monitored by
quenching of tryptophan fluorescence at 340 nm after excita-
tion at 295 nm; quenching indicates cofactor binding to the
apoenzyme. NADPH binding to the apoprotein was monitored
by enhancement of fluorescence emission at 440 nm (excitation
350 nm). Each fluorescence value measured in the presence of
the protein was corrected by subtracting the contribution of
unbound NADPH to the fluorescence. Inner filtering effects
were determined to be negligible at the enzyme and NADPH
concentrations used. For experiments involving higher concen-
trations of NADP the following correction was applied as
described (24),
Fc  Fobs  10
 Aex  Aem/ 2 (Eq. 1)
where Fc is the corrected intensity, Fobs is the observed inten-
sity, and Aex and Aem are the absorbance of sample at the exci-
tation and emission wavelengths, respectively.
Dissociation constants (KD) were determined by plotting the
corrected change in emission (F) against the concentration of
the titrant. The Prism 5.0 program (GraphPad) was used to fit
the data by nonlinear regression. For NADP titration, data
best fit a single binding site equation (Equation 2), where F is
the change in fluorescence, Fmax is the maximal change in
fluorescence, and X is the concentration of the titrant,
F  Fmax  X/KD  X (Eq. 2)
Conversely, data obtained after NADPH titration of both
PBCV-1 and ATCV-1 apoenzymes best fit one-site binding by
the Hill equation (Equation 3), where F is the change in fluo-
rescence,Fmax is themaximal change in fluorescence, is the
concentration of the titrant, and h is the Hill slope,
F  Fmax  X
h/KD  X
h (Eq. 3)
Size-exclusion Chromatography—The molecular mass of
GMD proteins was determined by size exclusion chromatogra-
phy (SEC) using a TSKgel G3000SWXL column, 7.8 300mm,
5-m particle size (Tosoh Biosciences). The mobile phase was
0.1 M sodium phosphate buffer, pH 6.7, containing 0.1 M
Na2SO4. The eluate was monitored at 220 nm. The following
proteins were used as standards: cytochrome C (12 kDa), car-
bonic anhydrase (29 kDa), ovalbumin (44 kDa), bovine serum
albumin (66 kDa), -globulin (157 kDa), and tyroglobulin (670
kDa). All protein standards were obtained from Sigma. Blue
dextran and DTT were used to determine the void and total
column volumes, respectively, to enable calculation of the dis-
tribution coefficient Kav according to the following equation
(25),
Kav  Ve  Vo/Vt  Vo (Eq. 4)
where Ve is the elution volume of the protein, Vo the column
void volume, and Vt is the total bed volume. The Kav for each
protein standard was plotted against the logarithm of the cor-
responding molecular mass. Kav of samples was used to calcu-
late the molecular mass by linear regression analysis.
Analysis of Enzyme Activities—GMD dehydratase activity
was assayed in TBSE containing 1mMDTT. Amixture of GDP-
D-[U-14C]mannose (GE Healthcare; specific activity 11.1 GBq/
mmol) and unlabeled GDP-D-mannose (Sigma) was used as
substrate at a final specific activity of 1.4 GBq/mmol. Assays
were conducted at 37 °C, and aliquots were withdrawn at vari-
ous times. Reactions were stopped by adding 10-l samples to
90 l of ice-cold water followed by extraction with sodium per-
chlorate/potassium acetate as previously described (26). The
conversion of GDP-D-[14C]mannose to GDP-4-keto-6-deoxy-
D-[14C]mannose was used to measure ATCV-1 GMD dehy-
dratase activity; the two sugar nucleotides were detected by
reverse phase HPLC followed by continuous flow scintillation
counting as described previously (9). For the experiments with
PBCV-1 proteins in the presence of NADPH, where bothGDP-
4-keto-6-deoxy-D-mannose and GDP-D-rhamnose are formed,
activity was determined by following GDP-D-mannose con-
sumption. GMD reductase activity was carried out in the same
Role of NADPH in GDP-D-mannose 4,6-Dehydratase
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conditions using different concentrations of NADPH and
GDP-4-keto-6-deoxy-D-[14C]mannose as substrate. GDP-4-
keto-6-deoxy-D-[14C]mannose was produced from GDP-D-
mannose using the GMD dehydratase activity in the absence of
added NADPH. Complete conversion of GDP-D-mannose to
GDP-4-keto-6-deoxy-D-mannose was followed by HPLC. The
sugar nucleotide was separated from GMD by ultrafiltration
using the Microcon YM-10 system (Amicon-Millipore). Heat-
inactivation of GMD was avoided, as we observed a significant
degradation of the product.
Phylogenetic Analyses—BLASTP searches for PBCV-1 GMD
(AAO67555) and PBCV-1GMER (AAC96663)were conducted
to construct two phylogenetic trees. Twenty taxa, including
prokaryotes, eukaryotes, Archaea, as well as one virus were
selected. The 20 taxa, which included PBCV-1 and ATCV-1,
were alignedwithClustalWusing the default setting in theBiol-
ogy Workbench. The alignments were converted to NEXUS
format and imported into PAUP 4.0b10 (27) for phylogenetic
analysis. Trees were constructed using the following three
methods:maximumparsimony heuristic, neighbor joining, and
maximum parsimony bootstrap (1000 replicates). Because the
PBCV-1GMDandGMERproteins have sequence homology to
one another, they were used as the out-groups to root the two
trees; i.e. PBCV-1 GMER was used to root the GMD tree,
whereas PBCV-1 GMD was used to root the GMER tree. The
GMD tree shown in Fig. 7 is a summary of the very similar tree
topologies from the three tree-buildingmethods. The values on
the branches are the percentage of bootstrap support (1000
replicates). Only bootstrap values 50% are reported.
RESULTS
Determination of Bound NADP/NADPH—The catalytic
mechanism proposed for GMDs requires NADP as the coen-
zyme to initiate the reaction. However, several observations
indicate that NADPH is also tightly bound to the enzyme (15–
16). Likewise, incubating GDP-4-keto-6-deoxy-D-mannose
with equimolar amounts of purified recombinant PBCV-1 and
ATCV-1 GMDs results in the appearance of GDP-D-rhamnose
without adding exogenous NADPH (results not shown). These
results suggest that NADPH is present and catalytically compe-
tent in the two recombinant viral GMDs. To address the pres-
ence and the possible role of NADPH in GMD activity, we
measured the coenzyme content in the two proteins by HPLC
(supplemental Figs. 1 and 2). To discriminate betweenNADPH
and NADP, the recombinant proteins were isolated under
conditions that selectively destroy either the oxidized or the
reduced form of the coenzyme. The HPLC analysis also
revealed another substance(s) bound to the purified proteins
that has a spectrum suggestive of a guanylate moiety (supple-
mental Figs. 1, A and B, and 2, A and B). For ATCV-1 GMD,
variable amounts of NADP and NADPH were detected with
different enzyme preparations (Table 1); these results indicate
that the ATCV-1 protein contains both forms of the coenzyme.
However, in all cases the additive amount of NADP and
NADPHwas about 1 mol/mol of monomeric ATCV-1 protein.
In contrast, PBCV-1 GMD contained primarily NADPH, and
only trace amounts of NADP were detected (Table 1).
Incubating the two viral GMDs with GDP-4-keto-6-deoxy-
D-mannose led to almost total conversion of NADPH to
NADP, resulting in about 1mol of the oxidized coenzyme per
mol of protein (Table 1). Similar results were obtained with
GDP-D-mannose as a substrate, suggesting that the enzymes
containing bound NADPH also catalyze the initial dehydration
reaction (results not shown). Preincubated GMDs, i.e. after all
the coenzyme was converted to the oxidized form, were then
subjected to dialysis followed by NADP determination. No
protein-associated coenzyme was detected after extensive dial-
ysis (supplemental Figs. 1C and 2C). Conversely, dialysis of the
untreated NADPH-containing GMD proteins had only slight
effects on the content of both coenzyme forms. These results
indicate that, whereas NADPH binds tightly to the viral GMDs,
NADP is easily dissociated from the proteins by dialysis. How-
ever, when untreated native ATCV-1 GMD was dialyzed, the
NADP already present in the protein remained bound to the
protein. These results suggest that reduced coenzyme confers a
different protein conformation that tightly binds the oxidized
form. The putative guanylate species observed in the untreated
native proteins were also present after dialysis, whereas they
were completely removed after dialysis of the GDP-4-keto-6-
deoxy-D-mannose-treated protein. This finding resembles the
results reported for UDP-galactose 4-epimerase, where the
NADPH-containing species has a significantly higher affinity
for the substrate analogs (28). Preincubation of the proteins
with GDP-4-keto-6-deoxy-D-mannose followed by extensive
dialysis was then used to produce apoenzymes for the experi-
ments described below.
Fluorescence Analysis—GMD fluorescent spectra were used
to confirm the presence of bound NADPH and its oxidation to
NADP after incubation with GDP-4-keto-6-deoxy-D-man-
nose. Both PBCV-1 andATCV-1GMDs gave a strong emission
with a maximum at 440 and 443 nm, respectively, after exci-
tation at 350 nm, thus confirming the presence of bound
NADPH (Fig. 2A). The blue shift in emission wavelength of the
protein-bound coenzyme compared with unbound NADPH
(maximum, 455 nm), and the enhanced fluorescence agreewith
previous reports (19). Incubation of the two GMDs with GDP-
4-keto-6-deoxy-D-mannose led to a complete disappearance of
the fluorescence, confirming the oxidation of bound NADPH
toNADP (Fig. 2A). Similarly, fluorescence spectra of the puri-
fied apoGMDs had no emission around 440 nm (not shown).
TABLE 1
Determination of GMD-bound NADP and NADPH
NADP and NADPH concentrations were determined by HPLC, as described
under “Experimental Procedures” using either freshly purified protein or after pre-
incubation of the enzymes with GDP-4-keto-6-deoxy-D-mannose.
PBCV-1 GMD ATCV-1 GMD
NADP NADPH NADP NADPH
mol/mol of protein monomer




0.85 	 0.10 0.07 	 0.02 0.92 	 0.12 0.06 	 0.03
a For ATCV-1 GMD, the ratio between NADP and NADPH varied considerably
between enzyme preparations, but in all cases the total amount of the coenzymes
was close to 1 mol/each mol of monomer. As a consequence, the range of
coenzyme concentrations was reported instead of the mean. All other data are
the means of coenzyme content derived from at least three recombinant pro-
tein preparations.
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Because amino acid sequence alignments indicated that
GMD contains a well conserved tryptophan residue in close
proximity to the active site (supplemental Fig. 3), we investi-
gated the fluorescent properties of the native protein after exci-
tation at 295 nm (Fig. 2B). Two emission peaks occurred; the
first one corresponded to tryptophan emission with a maxi-
mum at 336–338 nm, whereas the second one had a maximum
at about 440–443 nm, indicative of NADPH excitation by flu-
orescence energy transfer (29). When the enzymes were prein-
cubated with GDP-4-keto-6-deoxy-D-mannose, the peak
around 440 nm disappeared, and a significant increase in tryp-
tophan fluorescence emission occurred at 336–338 nm (Fig.
2B). These results suggest that boundNADPH induces quench-
ing of tryptophan fluorescence. When NADPH is oxidized to
NADP and the coenzyme is released from the protein, trypto-
phan quenching is lost. The emission spectrum of the purified
apoenzyme with excitation at 295 nm was identical to that
observed after treatment of the protein with GDP-4-keto-6-
deoxy-D-mannose (results not shown).
Two methods, fluorescence enhancement of NADPH after
binding to apoGMD and tryptophan fluorescence quenching
were used to determine theNADPHandNADP binding affin-
ities (KD), respectively, as reported previously for E. coli GMD
and Yersinia pseudotuberculosis CDP-glucose 4,6-dehydratase
(14, 19). ApoGMDwas prepared by dialysis, as described above,
and complete removal of the coenzymes was confirmed by
HPLC. Fluorescence enhancement by NADPH binding to
apoGMD is depicted in Fig. 3A. Analysis of the data by the
Prism 5.0 program indicated that they best fit a one-site Hill
binding equation. Apparent dissociation constant values of
0.71 	 0.07 and 4.0 	 0.2 M were obtained for PBCV-1 and
ATCV-1GMDs, respectively. TheHill slopewas 1.83	 0.35 for
PBCV-1 GMD and 2.46 	 0.19 for ATCV-1 GMD, suggesting
cooperativity. Thus, these results indicate that PBCV-1 GMD
has a higher affinity for NADPH than the ATCV-1 enzyme.
Titration of the apoGMDs with NADP is reported in Fig.
3B. We observed quenching of protein fluorescence after cor-
rection for the inner filtering effect. However, higher concen-
trations of NADP resulted in strong interference due to the
high absorbance of the coenzyme at the excitation wavelength
(295 nm). Using Equation 2 described under “Experimental
Procedures,” aFmax of 249	 20 with an apparentKD of 121	
20 M was calculated for ATCV-1 GMD. However, it was not
possible to calculate a NADP KD for the PBCV-1 enzyme.
Thus, the results confirm that the viral GMDs, and in particular
the PBCV-1 enzyme, have a very low affinity for NADP.
Size Exclusion Chromatography—The role of coenzyme
binding on the structural properties of PBCV-1 and ATCV-1
GMDs was examined by SEC. SEC of the PBCV-1-purified
active enzyme indicated that native PBCV-1 GMD elutes with
an apparent molecular mass of 87 kDa, suggesting a dimeric
structure in solution (Fig. 4A). To exclude any influence of pro-
tein conformation on the apparent molecular mass of PBCV-1
GMD (30), we conducted a parallel SEC analysis of GMD/
MUR1 from A. thaliana. Overall, the A. thaliana enzyme has
the same protein crystal structure (15, 17) as the PBCV-1
enzyme and was expected to have elution properties similar to
PBCV-1 GMD. The results obtained with the A. thaliana
enzyme indicated a mass of 160 kDa,3 corresponding to the
tetrameric form observed by x-ray crystallography (15). A fur-
ther demonstration of the oligomeric structure of PBCV-1
GMD in solution was obtained by BS3 (bis(sulfosuccinimid-
FIGURE 2. Fluorescence emission spectra of native GMDs and GMDs incu-
bated with GDP-4-keto-6-deoxy-D-mannose. The final protein concentra-
tion was 1 M in PBS. A, excitation was set at 350 nm. Native GMDs from both
PBCV-1 and ATCV-1 had an emission spectrum with a maximum at 440 and
443 nm, respectively. Treatment of the proteins with GDP-4-keto-6-deoxy-D-
mannose resulted in the loss of the fluorescence. B, excitation was set at 295
nm. Both proteins produced two emission peaks, with maxima at 336 and 440
nm for PBCV-1 GMD and 338 and 443 for ATCV-1 GMD, corresponding to
emission of tryptophan and bound NADPH, respectively. GMD preincubated
with GDP-4-keto-6-deoxy-D-mannose only had emission peaks at 336 and
338 nm, which displayed a highly increased fluorescence intensity.
FIGURE 3. Changes in fluorescence intensity during titration of apoGMDs
with increasing concentrations of NADPH and NADP. A, PBCV-1 and
ATCV-1 apoGMDs were diluted to 0.5 M in PBS and titrated with increasing
concentration of NADPH. The excitation wavelength was set at 350 nm. F
was obtained by subtracting the fluorescence intensity of NADPH solutions of
the same concentration used for titration from the fluorescence intensity of
the samples containing the protein. B, PBCV-1 and ATCV-1 apoGMDs were
diluted to 0.5 M in PBS and titrated with NADP. F was derived by subtrac-
tion of the fluorescence intensity of the protein with the added ligand from
the intensity of the protein solution without any added NADP.
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yl)suberate) cross-linking experiments of the native protein fol-
lowed by SDS-PAGE, as previously performed with human
GMD (31). The results revealed a main band migrating slightly
higher than the 75-kDa standard (results not shown), consist-
ent with a dimeric structure.
To evaluate the structural effects of converting NADPH to
NADP, 5 M PBCV-1 GMDwas incubated with GDP-4-keto-
6-deoxy-D-mannose and immediately subjected to SEC analy-
sis. The dimeric form was converted to a form with a higher
elution time, which was proportional to the amount of added
GDP-4-keto-6-deoxy-D-mannose. The new elution time was
observed also for the purified apoenzyme, which exhibited an
apparent mass of 52 kDa (Fig. 4B). This is higher than the
expected mass of the monomer (40 kDa), but it is compatible
with loss of the quaternary structure.
To determine whether the addition of coenzymes restores
the PBCV-1 GMD dimeric form, apoGMDwas incubated with
increasing concentrations of either NADPH or NADP.
NADPHaddition led to complete conversion of themonomeric
to the dimeric form, already at low coenzyme concentrations
(Fig. 4C). In contrast, no dimerization occurred when NADP
was added, even at millimolar concentrations. A progressive
decrease in the peak area corresponding to the monomer
occurred when NADP concentrations were higher than 5mM
(results not shown). A likely explanation is that the protein
aggregates in high concentrations ofNADP, which either pre-
cipitates out of solution or is retained on the column.
A similar elution behavior was observed for ATCV-1 GMD.
The protein containing both NADP and NADPH eluted as a
single peak, with an apparent molecular mass of 97 kDa (Fig.
4D). After incubationwithGDP-4-keto-6-deoxy-D-mannose to
convert NADPH to NADP, the elution time of the protein (at
5 M concentration) immediately after pretreatment was iden-
tical to that of untreated GMD (results not shown). If the
treated GMD was either diluted further or maintained at 4 °C
for 24 h, a new peak formedwith an apparentmolecularmass of
61 kDa (Fig. 4E). Like PBCV-1, ATCV-1 apoenzyme elutedwith
the same retention time as the new peak (not shown). Similarly
to PBCV-1GMD, incubation with increasing concentrations of
NADPHrestored the dimeric format 97 kDa (not shown). Con-
centrations ofNADP higher than 50M also promoted partial
formation of the dimer, at variance with the results from the
PBCV-1 enzyme; however, complete dimerization of the
ATCV-1 enzyme never occurredwith onlyNADP (results not
shown). Like PBCV-1 GMD, a loss of the ATCV-1 protein
occurred, probably as aggregation, when NADP was added at
millimolar concentrations.
Enzymatic Activities—PBCV-1 and ATCV-1 GMD dehy-
dratase and reductase activities are reported in Table 2. When
incubated in the presence of 100 M GDP-4-keto-6-deoxy-D-
FIGURE 4. Size exclusion chromatography of native and treated GMDs. A, native PBCV-1 GMD (5 M). B, purified PBCV-1 apoGMD (5 M). C, purified PBCV-1
apoGMD (5 M) incubated in the presence of NADPH (10 M). D, native ATCV-1 GMD (5 M). E, native ATCV-1 GMD incubated with molar excess of GDP-4-keto-
6-deoxy-D-mannose and kept at 4 °C for 24 h. mAU, milliabsorbance units. mAU, milliabsorbance units.
Role of NADPH in GDP-D-mannose 4,6-Dehydratase
JANUARY 4, 2008 • VOLUME 283 • NUMBER 1 JOURNAL OF BIOLOGICAL CHEMISTRY 189
  
mannose and exogenously addedNADPH, PBCV-1GMDhad a
high reductase activity, which is 1 order of magnitude higher
than the dehydratase activity. As predicted, the putative
ATCV-1GMDhad dehydratase activity withGDP-D-mannose.
However, no reductase activity was detected with the ATCV-1
GMD, which is similar to other GMDs. This finding indicates
that, even if the ATCV-1 enzyme is able to use the bound
NADPH to reduce GDP-4-keto-6-deoxy-D-mannose, it is not
able to exchange the bound NADP with the exogenous
NADPH, which is essential to perform the reductase activity.
GMD activity was also measured after pretreatment of the
concentrated protein (100 M) with GDP-4-keto-6-deoxy-D-
mannose (150M) to induce conversion ofNADPH toNADP.
Pretreatment of PBCV-1 GMD led to an immediate and com-
plete loss of dehydratase activity in all conditions tested. In
contrast, pretreatment ofATCV-1GMD,which completely con-
verted bound NADPH to NADP, resulted in an approximate
1.5-fold increase in dehydratase activity when the protein was
tested immediately after pretreatmentwith theGDP-4-keto-6-de-
oxy-D-mannose. If the pretreated protein was kept at a low con-
centration (5 M), it lost activity in 24 h, whereas the native
ATCV-1GMDretainedactivity.Whenbothnativeandpretreated
proteins were kept at 4 °C at high concentration (100 M), a pro-
gressive decrease (over several weeks) in the specific activity
occurred that was always faster for the pretreated protein.
After demonstrating that native recombinant PBCV-1 GMD
only binds NADPH and that conversion of NADPH to NADP
results in complete inactivation of the enzyme, the effects of
these two coenzymes were investigated using the apoenzyme.
As previously reported for E. coli GMD (14) and Y. pseudotu-
berculosis CDP-D-glucose 4,6-dehydratase (19), the apoGMD
was intrinsically inactive. We then incubated either 0.5 M
PBCV-1 native GMD or apoGMD and 50 MGDP-D-mannose
with increasing amounts of NADP or NADPH. Both NADP
and NADPH significantly increased native GMD activity (Fig.
5), confirming previous results with the PBCV-1 enzyme (9).
The addition of micromolar concentrations of NADPH to
apoGMD reactivated the enzyme, resulting in the synthesis of
both GDP-4-keto-6-deoxy-D-mannose and GDP-D-rhamnose
(directly proportional to the amount of NADPH added), due to
the combination of both dehydratase and reductase activities
(Fig. 5A). In contrast, dehydratase activity only occurred when
NADP concentrations were higher than 0.5 mM (Fig. 5B).
Activity of the ATCV-1 apoenzyme with either NADPH or
NADP using 100MGDP-D-mannose as substrate is reported
in Fig. 6. Like the PBCV-1 enzyme, NADPH alone reactivated
the ATCV-1 apoenzyme (Fig. 6A). However, unlike PBCV-1
GMD, no GDP-D-rhamnose formed, confirming that ATCV-1
GMD has no reductase activity. NADP also reactivated the
apoenzyme but at much higher concentrations than NADPH,
with a maximum at 0.5 mM. Additional increases in NADP
resulted in loss of enzymatic activity (Fig. 6B).
Phylogenetic Analyses—Maximum parsimony (heuristic),
neighbor joining (distance method), and maximum parsimony
using bootstrap (1000 replicates) analyses produced very simi-
lar tree topologies. The GMD phylogram shown in Fig. 7 was
constructed using the bootstrap algorithm in PAUP (27).
PBCV-1 GMD is the most evolutionary diverged of the taxa in
the tree. The long length of the horizontal lines in the tree and
the fact that PBCV-1 GMD is not a member of a clade indicate
extensive evolutionary divergence, whereas the ATCV-1 GMD
falls in a clade of bacterial GMDs. In contrast, the GMER tree
TABLE 2
Specific activity of GMD from PBCV-1 and ATCV-1 viruses
Specific activity was determined using 100 M 14C-labeled GDP-D-mannose or
GDP-4-keto-6-deoxy-D-mannose as substrates for dehydratase and reductase activ-
ities, respectively. Product formation was determined by reverse phase HPLC anal-
ysis followed by continuous flow scintillation counting. ND, not detected.
Specific activity
PBCV-1 GMD ATCV-1 GMD
mol/h/mg of protein
Dehydratase activity 28.6 	 8.3 37.6 	 7.3
Reductase activity 510.3 	 15.7 ND
FIGURE 5. Effects of NADP and NADPH on PBCV-1 apoGMD enzyme
activity. The enzyme activities of native GMD and apoGMD (both 0.5 M)
were determined with 50 M GDP-D-mannose as substrate. A, holoenzyme
and apoenzyme were incubated with increasing concentrations of NADPH.
Activity was expressed as the rate of disappearance of the substrate GDP-D-
mannose as determined by HPLC analysis because both GDP-4-keto-6-de-
oxy-D-mannose and GDP-D-rhamnose (directly proportional to the amount of
added NADPH) were produced. B, native GMD or the apoGMD were incu-
bated with increasing concentrations of NADP. Apoenzyme alone had no
activity.
Role of NADPH in GDP-D-mannose 4,6-Dehydratase
190 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 283 • NUMBER 1 • JANUARY 4, 2008
  
(supplemental Fig. 4) indicates that PBCV-1 and ATCV-1
GMERs are more similar to one another (same clade) than to
other taxa in the analysis.
DISCUSSION
GMD is a widely represented enzyme in all taxa, from bacteria
to animals and plants. Recently, GMD-encoding genes were iden-
tified in a few viruses, such as the chlorella viruses reported in this
paper and a cyanophage P-SSM2 infecting Prochlorococcus cya-
nobacteria (32). GMD is involved in the first step of the de novo
biosynthesis of GDP-L-fucose, the donor substrate for fucosyl-
transferase activity. Fucose is found in many glycoconjugates of
prokaryotes and eukaryotes, where it often plays a fundamental
role in cell-cell adhesion and recognition (33).Genes encoding the
second enzyme in the pathway, GMER, were also identified in the
chlorella viruses and in cyanophage P-SSM2, suggesting that the
synthesis of GDP-L-fucose plays an important role in their life
cycles, but this is unknown at the present time. Interestingly, all
these viruses infect photosynthetic organisms.
The presence of a tightly bound NADP is essential for the
proposed catalytic activity ofGMD (34, 35), as demonstrated by
the complete loss of activity by the apoenzyme (14). However,
recentGMDcrystal structures at 2.2Å resolution fromA. thali-
ana and P. aeruginosa indicate unambiguously the presence of
NADPH, and not NADP, bound to the proteins (15–16).
Unfortunately, the low resolution of the PBCV-1 structure did
not allow the oxidized and reduced forms of the coenzyme to be
distinguished (17). Likewise, the reduced coenzymeNADHwas
present in recombinant CDP-D-glucose 4,6-dehydratase (19).
The occurrence of NADH together with NAD has also been
reported for UDP-glucose 4-epimerase and dTDP-D-glucose
4,6-dehydratase, suggesting that a bound reduced coenzyme is
a common feature of many enzymes in the reductase-epime-
FIGURE 6. Effects of NADP and NADPH on ATCV-1 apoGMD activity. The
enzyme activities of native GMD and apoGMD (both 0.5 M) were determined
with 100 M GDP-D-mannose as substrate. A, holoenzyme and apoenzyme were
incubated with increasing concentrations of NADPH. Activity was expressed as
the rate of GDP-4-keto-6-deoxy-D-mannose formation determined by HPLC anal-
ysis. GDP-D-rhamnose was not detected in these conditions. B, native GMD or
apoGMD was incubated with increasing concentrations of NADP. No activity
was observed for the apoenzyme without adding coenzyme.
FIGURE 7. Rooted phylogram of GMD. A BLAST search was conducted using
the virus PBCV-1 GMD protein (PBCV-1: AAC96486). The sequence for ATCV-1
(A. turfacea chlorella virus) GMD is open reading frame Z804L in accession
number EF101928. The sequence for PBCV-1) (AAC96663) was used as the
out-group in the phylogenetic analyses. ClustalW was used to align the
sequences. Bootstrap analysis (heuristic using parsimony) was used to con-
struct the tree. Similar tree topologies were produced by neighbor joining
and maximum parsimony analyses. The values on the branches are the per-
centage of bootstrap support (1000 replicates). Only bootstrap values 50%
are shown. BA, bacteria Actinobacteria; BB, bacteria Bacteroidetes; BF, bacte-
ria Firmicutes; BP, bacteria Proteobacteria; Ar, Archaea; Me, Metazoa; Pl,
plants; Vi, double-stranded DNA virus. Accession numbers are as follows:
Agrobacterium tumefaciens strain C58 (AAL45583); A. thaliana (AAF07199);
Bacteroides fragilis (AAL61891); Caenorhabditis elegans (CAC42270); Clostrid-
ium acetobutylicum (AAK80138); Cyanophage P-SSM2 (YP_214488); Drosoph-
ila melanogaster (AAL90257); E. coli (1DB3); Homo sapiens (AAC13553); Meth-
anosarcina acetivorans strain C2A (AAM04594); Mycobacterium avium
(AAD20373); Mycobacterium tuberculosis CDC155 (AAK45828); Rhizobium sp.
NGR234 (AAB91604); Salmonella typhimurium (AAG24813); Vibrio vulnificus
(NP_933142); Y. pseudotuberculosis (ZP_00794554); Zea mays (AAF70818).
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rase-dehydrogenase superfamily (28, 36). Crystal structures of
some of these enzymes have been obtained with the oxidized
coenzyme, NAD (37–39), whereas in the case of GMDs, crys-
tals were obtained either without any coenzyme or with only
bound NADPH (14–16).
The presence of NAD(P)H is not completely surprising, since
these enzymes have a higher affinity for the reduced form of the
coenzyme, as compared with NAD(P) (14, 19). In fact, the high
affinityof theenzymes forNAD(P)Hcouldprevent itsdissociation
during the catalytic cycle, when the hydride is transiently trans-
ferred from sugar C-4 to the coenzyme. However, in all these
reports, the NAD(P)H-containing enzymes have been viewed as
abortive forms, devoid of enzymatic activity (28, 36).
Analysis of dinucleotide content in freshly purified recombi-
nant viral GMDs revealed variable ratios of NADP toNADPH
for the ATCV-1 enzyme and onlyNADPH for the PBCV-1 pro-
tein. It is possible that, under the expression conditions of the
recombinant proteins, most of the protein molecules bind
NADPH instead ofNADP, and this confers amore stable con-
formation. If the NADPH-containing protein is viewed as an
abortive form, oxidation ofNADPH toNADP should result in
the recovery of enzymatic activity. Indeed, oxidation of
NADPH in ATCV-1 GMD led to an initial increase in the
enzyme specific activity but only when the enzyme was kept at
high concentrations and for a short time. In contrast, NADPH
oxidation of PBCV-1 GMD resulted in a complete and imme-
diate loss of the dehydratase activity. The loss of the enzymatic
activity for both enzymes was accompanied by release of the
bound oxidized coenzyme and conversion of the dimeric struc-
ture to a monomeric form. Thus, the data reported here indi-
cate that viral GMDs in solution not only contain NADPH but
that NADPH is essential for protein structure and activity.
These results were confirmed by the experiments with the
apoenzymes, which establish that NADPH is more efficient in
restoring both structure and enzymatic activity of the viral
GMDs. Furthermore, the results indicate that NADP alone
does not promote subunit dimerization but that it induces
aggregation or precipitation of the proteins when used at mil-
limolar concentrations. Thus, the correct conformation of the
apoenzyme probably does not occur with only NADP.
When PBCV-1 and ATCV-1 recombinant GMDs were
maintained at 4 °C for several weeks, we observed a gradual loss
in NADPH content. This loss might be due to oxidation, which
occurred faster for the ATCV-1 enzyme and which paralleled a
decrease in its enzymatic activity and conversion of its dimeric
form to the monomeric form.3 Thus, oxidation of bound
NADPH could explain the intrinsic instability reported for sev-
eral GMDs (2, 31). Oxidation of NADPH by the product of the
dehydration reaction could also provide a mechanism to con-
trol the activity of the whole GDP-L-fucose pathway. In fact, in
vivo the intermediate GDP-4-keto-6-deoxy-D-mannose is
immediately converted to the final product GDP-L-fucose by
the GMER enzyme. GDP-L-fucose is then responsible for feed-
back inhibition of GMD (7, 31). If GMER activity does not
remove the intermediate compound efficiently, GDP-4-keto-6-
deoxy-D-mannose accumulation could result in destabilization of
GMD, thus blocking GDP-D-mannose consumption, an essential
metabolite for all glycosylation processes. Co-expression of
A. thalianaMUR1/GMD with its corresponding GMER resulted
inGMDstabilizationand increaseddehydratase activity; however,
in this report a direct interaction between the two enzymes was
postulated (40). Studies on the functional properties of eukaryotic
GMDs are currently in progress to test this hypothesis. Indeed,
preliminary data on human GMD indicates the presence of both
tightly bound NADP and NADPH as well as incubation of the
proteinwith the intermediate compound inducedoxidationof the
bound coenzyme, similar to the data reported in this study.3 Inter-
estingly, results reported for recombinant human and E. coli
GMDs showed severalfold increases in enzymatic activity when
micromolar concentrations of NADPH were added, suggesting
that NADPH also plays an important role in the bacterial and
eukaryotic enzymes (7).
The presence of one NADP and one NADPH in each func-
tional dimer of ATCV-1 GMD is compatible with the proposed
catalytic mechanism such that NADP is essential for enzy-
matic activity, whereas NADPH is essential for stabilizing the
protein structure. However, the PBCV-1 GMD differs signifi-
cantly from the ATCV-1 GMD because the purified PBCV-1
recombinant enzyme contains tightly bound NADPH and
NADP is only present in trace amounts in freshly purified
protein. In this condition the protein displays full enzymatic
activity. Binding of NADPH instead of NADP to purified
PBCV-1 GMD raises questions about its catalytic mechanism,
since the only proposedmechanism requires the presence of an
oxidized coenzyme. At present, we do not have an explanation
for this finding nor are we able to propose an alternative mech-
anism. Furthermore, the low resolution of PBCV-1 x-ray struc-
ture does not provide any clues to explain this finding. How-
ever, GMD amino acid alignments reveal some differences in
conserved stretches of amino acids, which are in close proxim-
ity to the active site; these differences only occur in the PBCV-1
enzyme. Thus, at least some of these amino acid substitutions
(in particular several cysteine residues, highlighted in GMD
alignment in supplemental Fig. 3) are undoubtedly responsible
for the differences observed between GMD from PBCV-1 and
those from the other. Direct comparisons of the properties
between the virus GMDs and GMDs from other organs as well
as currently ongoing site-directed mutagenesis experiments
should provide an explanation for this issue and also for the
high reductase activity, leading toGDP-D-rhamnose formation,
displayed by only the PBCV-1 enzyme.
The different affinities for NADP/NADPH by the ATCV-1
and PBCV-1 GMDs could in part explain the different enzy-
matic properties between the two proteins. In fact, the
extremely low affinity of the PBCV-1 enzyme for NADP
together with a high affinity for NADPH could lead to NADPH
replacing NADP. This replacement could explain the high
reductase activity by the PBCV-1 enzyme. In contrast, this
replacement probably does not occur for the ATCV-1 enzyme,
which has a lower affinity toward NADPH and higher affinity
toward NADP compared with the PBCV-1 GMD. This differ-
ence could explain the lack of reductase activity.
The unusual catalytic behavior of PBCV-1 GMD compared
with ATCV-1 is also reflected in amino acid sequence differ-
ences. ATCV-1 GMD is more similar to GMDs from other or-
ganisms than it is to PBCV-1 GMD. For example, ATCV-1 and
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PBCV-1 GMDs have 66 and 56% identity with the Yersinia
enterocolitica enzyme, respectively, whereas the identity
between the two viral enzymes is only 53%. This difference is
also reflected in the phylogenic analyses, which indicates that
PBCV-1GMD is themost evolutionarily diverged of theGMDs,
whereas ATCV-1 GMD clusters with bacterial GMDs.
The phylogenetic analyses help form hypotheses about past
evolutionary events. One hypothesis is that PBCV-1 GMD is
older than ATCV-1 GMD, which would indicate that the two
viruses acquired their GMDs by separate events in evolutionary
time. If this hypothesis is correct, then it is difficult to explain
why GMER, which completes the second step in the pathway
from mannose to fucose, is so similar for the two viruses (sup-
plemental Fig. 4). A second hypothesis, and onewe favor, is that
both GMD and GMER genes were acquired by the ancestor of
PBCV-1 and ATCV-1 before their divergence. The high degree
of similarity between the PBCV-1 and ATCV-1 GMERs (sup-
plemental Fig. 4) supports this hypothesis.We propose that the
high degree of evolutionary divergence between PBCV-1 and
ATCV-1 GMDs occurred because the former evolved a sec-
ond enzymatic function after the divergence of the PBCV-1
and ATCV-1 viruses from their common ancestor. PBCV-1
GMD evolved faster than ATCV-1 GMD because it faced
two evolutionary pressures, one to remain as a functional
dehydratase (continue as an ortholog) and the second to
become a new reductase (become a new paralog that could
synthesize rhamnose). It is the second evolutionary pressure
that would have required many amino acid substitutions in
PBCV-1 GMD, as compared with ATCV-1 GMD that did not
evolve new reductase activity. In fact, accumulating evidence
indicates that the chlorella viruses, including PBCV-1 and
ATCV-1, have a long evolutionary history (41), possibly dating
back to the time that prokaryotic and eukaryotic organisms
separated,2.0–2.7 billion years ago (42–45). Although we do
not have an estimate of the time since the divergence of the
PBCV-1 and ATCV-1 viruses, there was likely enough time,
particularly when considering the short life cycle of a virus, to
allow for the evolution of reductase activity in PBCV-1 GMD.
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Legends to figures (Supplemental data) 
 
Figure 1. HPLC analysis of the coenzymes bound to PBCV-1 GMD. (A) Native protein extracted with 
NaOH to determine bound NADPH. (B) Native protein extracted with perchloric acid to determine bound 
NADP
+
. (C) Apo-GMD obtained after treatment with GDP-4-keto-6-deoxy-D-mannose and dialysis, 
followed by perchloric acid extraction. Arrows indicate the elution time of standard NADP
+
 and NADPH. 
Letter G denotes peaks that exhibit a guanylate spectrum.  
 
Figure 2. HPLC analysis of the coenzymes bound to ATCV-1 GMD. (A) Freshly purified GMD extracted 
with NaOH to determine bound NADPH. (B) Freshly purified GMD extracted with perchloric acid to 
determine bound NADP
+
. (C) Apo-GMD obtained after treatment with GDP-4-keto-6-deoxy-D-mannose and 
dialysis, followed by perchloric acid extraction. Arrows indicate the elution time of standard NADP
+
 and 
NADPH. Letter G denotes peaks that exhibit a guanylate spectrum. 
 
Figure 3. Sequence alignment of GMDs. ClustalW was used to align the sequences of ATCV-1, PBCV-1 
(AAC96486),  H. sapiens (AAC13553), E. coli (1DB3A) and A. thaliana (mur1, P93031) GMDs. Box 
indicates the GXXGXXG motif involved in coenzyme binding. Arrows indicate the residues involved in the 
catalytic mechanism. Cysteine residues, which are present in PBCV-1 GMD only and which are in close 
proximity to the active site, are highlighted in jellow.  
Figure 4. Rooted phylogram of GDP-4-keto-6-deoxy-D-mannose epimerase/reductase (GMER).  A 
BLAST was conducted using the GMER gene of PBCV-1: AAC96663. The sequence for ATCV-1 GMER 
corresponds to ORF Z282L in GenBank accession number EF101928. The sequence for GDP-D-mannose 
dehydratase (GMD) (AAC96486) was used as the outgroup in the phylogenetic analyses.ClustalW was used 
to align the sequences. Maximum parsimony was used to construct the tree. Similar tree topologies were 
produced by neighbor joining and bootstrap analyses. The values on the branches are the percentage of 
bootstrap support (1000 replicates). Only bootstrap values > 50% are shown. Key: BA = Bacteria 
Actinobacteria; BB = Bacteria Bacteroidetes; BF = Bacteria Firmicutes; BP = Bacteria Proteobacteria; BT = 
Bacteria Thermotogae; Ar = Archaea; Me = Metazoa; Pl = Plants; Vi = dsDNA virus. Accession numbers are 
as follows: Agrobacterium tumefaciens str. C58 (AAK88659); Azorhizobium caulinodans (AAB24744); 
Bacteroides fragilis (AAL61890); Bradyrhizobium sp. WM9 (AAK00171); Caenorhabditis elegans 
(AAA50647); Campylobacter jejuni (CAB73852); Clostridium acetobutylicum (AAK80137); Drosophila 
melanogaster (AAF46924); Escherichia coli1E6U (1E6U); Homo sapiens (AAC50786); Laminaria digitata 
(CAB61336); Methanococcus jannaschii (AAB98196); Methanosarcina acetivorans (AAM04606); 
Mycobacterium tuberculosis (AAK45829); Pyrococcus furiosus (AAL81912); Salmonella typhimurium 
(AAL21012); Thermotoga maritima (AAD35594); Vibrio cholerae (BAA33627).  
 








Figure 3 –Supplemental data 
 
 
ATCV-1           --------------------MDSSTFVPKRALVTGITGQDGSYLAEFLINIGYVVHGIKR 40 
PCBV-1           -------------------------MLSKVALVTGATGQDGTYLCPFLVKKGYTVYGLVR 35 
H. sapiens       -----MAHAPARCPSARGSGDGEMGKPRNVALITGITGQDGSYLAEFLLEKGYEVHGIVR 55 
E. coli          --------------------MN------KVALITGITGQDGSYLAELLLEKGYEVHGIKR 34 
A. thaliana      MASENNGSRSDSESITAPKADSTVVEPRKIALITGITGQDGSYLTEFLLGKGYEVHGLIR 60 
                                             : **:** *****:**  :*:  ** *:*: * 
 
ATCV-1           RSSQLNTQRIDALY-DKYSE-SGQLVLHYGDLTDSTNLVKIVQQVKPDEVYNLGAQSHVQ 98 
PCBV-1           HTSSENP-RVEELKSQ-------GVEIVHGDLTDSASLINIITKIRPDEIYNMAAQSFVG 87 
H. sapiens       RSSSFNTGRIEHLYKNPQAHIEGNMKLHYGDLTDSTCLVKIINEVKPTEIYNLGAQSHVK 115 
E. coli          RASSFNTERVDHIYQDSHLA-NPKLFLHYGDLTDTSNLTRILKEVQPDEVYNLGAMSHVA 93 
A. thaliana      RSSNFNTQRINHIYIDPHNVNKALMKLHYADLTDASSLRRWIDVIKPDEVYNLAAQSHVA 120 
                 ::*. *. *:: :  :        : : :.****:: * . :  ::* *:**:.* *.*  
 
ATCV-1           VSFEMPEYTADVDGMGTLRLLEAIRICGLEKT--TKFYQASTSELFGKVREIPQKITTPF 156 
PCBV-1           DSFHQAEVTANVDALGVLRLLDAVRIAGLNS----RICQASTSELYGKVQEIPQTERTPF 143 
H. sapiens       ISFDLAEYTADVDGVGTLRLLDAVKTCGLINS--VKFYQASTSELYGKVQEIPQKETTPF 173 
E. coli          VSFESPEYTADVDAIGTLRLLEAIRILGLEKK--TKFYQASTSELYGLVQEIPQKETTPF 151 
A. thaliana      VSFEIPDYTADVVATGALRLLEAVRSHTIDSGRTVKYYQAGSSEMFGSTPP-PQSETTPF 179 
                  **. .: **:* . *.****:*::   : .    :  **.:**::* .   **.  *** 
 
ATCV-1           HPRSPYAVAKMFAYWTVVNYREAYGMFACNGILFNHESPLRGETFVTRKITRGLARVKLG 216 
PCBV-1           YPRSPYGVAKLYAYWICKNYRESYGMFVCNSICFNHESPNRGHQFVTRKITKAVANIFNG 203 
H. sapiens       YPRSPYGAAKLYAYWIVVNFREAYNLFAVNGILFNHESPRRGANFVTRKISRSVAKIYLG 233 
E. coli          YPRSPYAVAKLYAYWITVNYRESYGMFACNGILFNHESPRRGETFVTRKITRGIANIAQG 211 
A. thaliana      HPRSPYAASKCAAHWYTVNYREAYGLFACNGILFNHESPRRGENFVTRKITRALGRIKVG 239 
                 :*****..:*  *:*   *:**:*.:*. *.* ****** **  ******::.:..:  * 
 
ATCV-1           KQKCLFLGNMDAKRDWGHARDYVEAMWKMLQSPEPEDFVIATGVQYSVKDFVNETCKALG 276 
PCBV-1           VEKCMYLGNIDSKRDWGYAEDYIEAMWLMLQQDTPDDYVIATGQTTSVREFVKIAFGVLD 263 
H. sapiens       QLECFSLGNLDAKRDWGHAKDYVEAMWLMLQNDEPEDFVIATGEVHSVREFVEKSFLHIG 293 
E. coli          LDKCLYLGNMDSLRDWGHAKDYVKMQWMMLQQETPEDFVIATGIQYSVREFVTMAAEQVG 271 
A. thaliana      LQTKLFLGNLQASRDWGFAGDYVEAMWLMLQQEKPDDYVVATEEGHTVEEFLDVSFGYLG 299 
                     : ***::: ****.* **::  * ***.  *:*:*:**    :*.:*:  :   :. 
 
ATCV-1           MSIEWQGEGEHTRAVNPST----------GEVFVAVNSRYYRPAEVETLLGDATEAKEKL 326 
PCBV-1           IVVEFSGENENEIAYVVSSP--EASHVKVGDVVMRVNKDFYRPAEVDLLVGDATKAKSVL 321 
H. sapiens       KTIVWEGKNENEVGRCKET----------GKVHVTVDLKYYRPTEVDFLQGDCTKAKQKL 343 
E. coli          IELAFEGEGVNEKGVVVSVNGTDAKAVNPGDVIISVDPRYFRPAEVETLLGDPTNAHKKL 331 
A. thaliana      --LNWKD-------------------------YVEIDQRYFRPAEVDNLQGDASKAKEVL 332 
                   : :..                          : ::  ::**:**: * ** ::*:. * 
 
ATCV-1           GWSPRTSFEDLVKEMALADLEIAKRE--------------- 352 
PCBV-1           GWEPKTTLNELVKMMVISDTFGNK----------------- 345 
H.sapiens        NWKPRVAFDELVREMVHADVELMRTNPNA------------ 372 
E. coli          GWSPEITLREMVKEMVSSDLAIAKKNVLLKANNIATNIPQE 372 
A. thaliana      GWKPQVGFEKLVKMMVDEDLELAKREKVLVDAGYMDAKQQP 373 
                 .*.*.  : .:*: *.  *    :                  
 
 
Figure 4 –Supplemental data 
 
 
